CERS

Cerus
CERS

Last Price

Financial Snapshot

gainify

Market Data

Market Cap
$281.80M
EV
$303.41M
Shares Outstanding
191.70M
Beta
1.57
Industry
Medical - Devices

Wall Street View

Analyst Rating
BUY
Analyst Target Price
Number of Analysts
3
P/E 2025E
-
P/Revenue 2025E
1.29x

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About Cerus Corporation

gainify
CERS

Cerus Corporation

CERS

Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is d...

Sector

Healthcare

Industry

Medical - Devices

CEO

Greenman, William

Employees

622

IPO Date

1997-01-31

Headquarters

1220 Concord Avenue, Suite 600, Concord, California, 94520, United States

gainifypowered-by-sp
Socials
Send us an emailFollow us on XConnect with us on LinkedInFollow us on InstagramFollow us on ThreadsCheck us out on TrustpilotFollow us on YouTubeFind us on Google Maps

Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2025, S&P Global Market Intelligence. All rights reserved.

View Data Providers

NEWSLETTER

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

© 2025 Gainify. All rights reserved.